These results illustrated that the massive glucose consumption and ROS production in tumors caused by GR@MMSNs-P could not only effectively inhibit the primary tumor growth but also significantly enhance the Twist-silencing efficiency, eventually resulting in prominent inhibition performance on breast cancer growth and pulmonary metastasis. The gene discussed is TWIST1; the disease is breast carcinoma.